脑梗死因发病率及致残率高,其治疗越来越受到重视。近2年,我们应用巴曲酶注射液(东菱迪芙.北京东菱医药生物科技有限公司生产)治疗急性脑梗死30例取得满意疗效,现报告如下。1资料和方法1.1一般资料60例均为发病72h以内经CT确诊为脑梗死患者。随机分为治疗组30例,男19例,女11例; Due to the morbidity and disability rate of cerebral infarction, its treatment is more and more attention. The past two years, we use batroxobin injection (Dongling Duff. Beijing Dongling Pharmaceutical Biotechnology Co., Ltd.) in the treatment of acute cerebral infarction in 30 cases to obtain satisfactory results, are as follows. 1 Materials and Methods 1.1 General Information 60 cases were diagnosed as cerebral infarction within 72h by CT. Randomly divided into treatment group 30 cases, 19 males and 11 females;